Variant report
Variant | nsv1032902 |
---|---|
Chromosome Location | chr6:65063881-65114111 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:53)
- CpG islands (count:61)
- Chromatin interactive region (count:7)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CHD2 | chr6:65084655-65084659 | HepG2 | liver: | n/a | n/a |
2 | CTCF | chr6:65063780-65063930 | HBMEC | blood vessel: | n/a | n/a |
3 | E2F4 | chr6:65077027-65077090 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | FOXA1 | chr6:65099961-65100294 | HepG2 | liver: | n/a | n/a |
5 | FOXA1 | chr6:65099224-65099535 | T-47D | breast: | n/a | n/a |
6 | FOXA2 | chr6:65099868-65100292 | A549 | lung: | n/a | n/a |
7 | FOXA2 | chr6:65099782-65100428 | A549 | lung: | n/a | n/a |
8 | GATA3 | chr6:65099240-65099524 | T-47D | breast: | n/a | n/a |
9 | GATA3 | chr6:65065528-65065691 | SH-SY5Y | brain: | n/a | n/a |
10 | GATA3 | chr6:65099289-65099421 | MCF-7 | breast: | n/a | n/a |
11 | GATA3 | chr6:65099208-65099717 | MCF-7 | breast: | n/a | n/a |
12 | GATA3 | chr6:65110306-65110591 | SH-SY5Y | brain: | n/a | n/a |
13 | GATA3 | chr6:65099254-65099472 | T-47D | breast: | n/a | n/a |
14 | GATA3 | chr6:65098948-65099700 | MCF-7 | breast: | n/a | n/a |
15 | JUN | chr6:65086400-65086545 | H1-hESC | embryonic stem cell: | n/a | n/a |
16 | JUND | chr6:65086152-65086668 | H1-hESC | embryonic stem cell: | n/a | n/a |
17 | KAP1 | chr6:65081694-65082000 | HEK293 | kidney: | n/a | n/a |
18 | MAFF | chr6:65085905-65086194 | HepG2 | liver: | n/a | n/a |
19 | MAFF | chr6:65109380-65109604 | HepG2 | liver: | n/a | chr6:65109489-65109507 |
20 | MAFK | chr6:65085889-65086185 | HepG2 | liver: | n/a | n/a |
21 | MAFK | chr6:65089973-65090032 | HepG2 | liver: | n/a | chr6:65089982-65089996 chr6:65089983-65089994 chr6:65089983-65089994 chr6:65089983-65089999 |
22 | MAFK | chr6:65085931-65086191 | HepG2 | liver: | n/a | n/a |
23 | MAFK | chr6:65109367-65109591 | HepG2 | liver: | n/a | chr6:65109490-65109505 chr6:65109473-65109487 |
24 | MAFK | chr6:65085909-65086174 | IMR90 | lung: | n/a | n/a |
25 | MAFK | chr6:65109357-65109737 | HepG2 | liver: | n/a | chr6:65109490-65109505 chr6:65109473-65109487 |
26 | MAFK | chr6:65091589-65091820 | HepG2 | liver: | n/a | chr6:65091725-65091739 chr6:65091722-65091738 |
27 | MAX | chr6:65108045-65108259 | NB4 | blood: | n/a | n/a |
28 | NR2F2 | chr6:65099300-65099542 | MCF-7 | breast: | n/a | n/a |
29 | POLR2A | chr6:65094217-65094417 | MCF10A-Er-Src | breast: | n/a | n/a |
30 | POLR2A | chr6:65066592-65066659 | MCF10A-Er-Src | breast: | n/a | n/a |
31 | POLR2A | chr6:65077099-65077299 | MCF10A-Er-Src | breast: | n/a | n/a |
32 | POLR2A | chr6:65094554-65094842 | H1-neurons | neurons: | n/a | n/a |
33 | POLR2A | chr6:65068177-65068364 | MCF10A-Er-Src | breast: | n/a | n/a |
34 | POLR2A | chr6:65099890-65100064 | H1-hESC | embryonic stem cell: | n/a | n/a |
35 | POLR2A | chr6:65070456-65070656 | MCF10A-Er-Src | breast: | n/a | n/a |
36 | POLR2A | chr6:65069246-65069316 | MCF10A-Er-Src | breast: | n/a | n/a |
37 | POLR2A | chr6:65099926-65100117 | H1-hESC | embryonic stem cell: | n/a | n/a |
38 | POLR2A | chr6:65112343-65112599 | H1-neurons | neurons: | n/a | n/a |
39 | POLR2A | chr6:65099640-65099762 | K562 | blood: | n/a | n/a |
40 | POLR2A | chr6:65099660-65099780 | H1-hESC | embryonic stem cell: | n/a | n/a |
41 | RFX5 | chr6:65086468-65086583 | H1-hESC | embryonic stem cell: | n/a | n/a |
42 | SETDB1 | chr6:65081659-65082139 | U2OS | brain: | n/a | n/a |
43 | SIN3AK20 | chr6:65099252-65099565 | MCF-7 | breast: | n/a | n/a |
44 | SIN3AK20 | chr6:65099132-65099717 | MCF-7 | breast: | n/a | n/a |
45 | SPI1 | chr6:65069564-65069888 | HL-60 | blood: | n/a | n/a |
46 | STAT3 | chr6:65073811-65073880 | MCF10A-Er-Src | breast: | n/a | n/a |
47 | STAT3 | chr6:65097383-65097606 | MCF10A-Er-Src | breast: | n/a | n/a |
48 | STAT3 | chr6:65106958-65107011 | MCF10A-Er-Src | breast: | n/a | n/a |
49 | STAT3 | chr6:65110757-65110957 | MCF10A-Er-Src | breast: | n/a | n/a |
50 | STAT3 | chr6:65096413-65096790 | MCF10A-Er-Src | breast: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:65099958-65100008 | Hepatocyte | liver: | n/a |
2 | chr6:65099958-65100008 | AG10803 | skin: | n/a |
3 | chr6:65099958-65100008 | IMR90 | lung: | fetal |
4 | chr6:65099958-65100008 | CMK | blood: | n/a |
5 | chr6:65099958-65100008 | BE2_C | brain: | n/a |
6 | chr6:65099958-65100008 | GM19239 | blood: | n/a |
7 | chr6:65099958-65100008 | A549 | lung: | n/a |
8 | chr6:65099958-65100008 | PFSK-1 | brain: | n/a |
9 | chr6:65099958-65100008 | HMEC | breast: | n/a |
10 | chr6:65099958-65100008 | GM06990 | blood: | n/a |
11 | chr6:65099958-65100008 | SKMC | muscle: | n/a |
12 | chr6:65099958-65100008 | AG09319 | gingival: | n/a |
13 | chr6:65099958-65100008 | SAEC | small airway: | n/a |
14 | chr6:65099958-65100008 | SK-N-SH | brain: | n/a |
15 | chr6:65099958-65100008 | LNCaP | prostate: | n/a |
16 | chr6:65099958-65100008 | ProgFib | skin: | n/a |
17 | chr6:65099958-65100008 | Jurkat | blood: | n/a |
18 | chr6:65099958-65100008 | NB4 | blood: | n/a |
19 | chr6:65099958-65100008 | HIPEpiC | eye: | n/a |
20 | chr6:65099958-65100008 | AG04450 | lung: | fetal |
21 | chr6:65099958-65100008 | HEEpiC | esophagus: | n/a |
22 | chr6:65099958-65100008 | HAEpiC | amniotic membrane: | n/a |
23 | chr6:65099958-65100008 | HRPEpiC | eye: | n/a |
24 | chr6:65099958-65100008 | GM12891 | blood: | n/a |
25 | chr6:65099958-65100008 | HCT-116 | colon: | n/a |
26 | chr6:65099958-65100008 | SK-N-MC | brain: | n/a |
27 | chr6:65099958-65100008 | HNPCEpiC | eye: | n/a |
28 | chr6:65099958-65100008 | MCF10A-Er-Src | breast: | n/a |
29 | chr6:65099958-65100008 | HUVEC | blood vessel: | n/a |
30 | chr6:65099958-65100008 | PrEC | prostate: | n/a |
31 | chr6:65099958-65100008 | HRCEpiC | kidney: | n/a |
32 | chr6:65099958-65100008 | HCM | heart: | n/a |
33 | chr6:65099958-65100008 | NH-A | brain: | n/a |
34 | chr6:65099958-65100008 | RPTEC | kidney: | n/a |
35 | chr6:65099958-65100008 | HCPEpiC | choroid plexus: | n/a |
36 | chr6:65099958-65100008 | GM12878 | blood: | n/a |
37 | chr6:65099958-65100008 | AoSMC | blood vessel: | n/a |
38 | chr6:65099958-65100008 | U87 | brain: | n/a |
39 | chr6:65099958-65100008 | HL-60 | blood: | n/a |
40 | chr6:65099958-65100008 | HRE | kidney: | n/a |
41 | chr6:65099958-65100008 | AG04449 | skin: | fetal |
42 | chr6:65099958-65100008 | T-47D | breast: | n/a |
43 | chr6:65099958-65100008 | HEK293 | kidney: | embryo |
44 | chr6:65099958-65100008 | AG09309 | skin: | n/a |
45 | chr6:65099958-65100008 | MCF-7 | breast: | n/a |
46 | chr6:65099958-65100008 | BJ | skin: | n/a |
47 | chr6:65099958-65100008 | HPAEpiC | pulmonary alveolar: | n/a |
48 | chr6:65099958-65100008 | Hela-S3 | cervix: | n/a |
49 | chr6:65099958-65100008 | SK-N-SH_RA | brain: | n/a |
50 | chr6:65099958-65100008 | HepG2 | liver: | n/a |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:65090547..65093920-chr6:65096939..65100016,3 | MCF-7 | breast: | |
2 | chr6:65070131..65072480-chr6:65075607..65077474,2 | MCF-7 | breast: | |
3 | chr6:65090547..65093920-chr6:65096939..65100016,3 | MCF-7 | breast: | |
4 | chr6:65105555..65108214-chr6:65112608..65114216,2 | K562 | blood: | |
5 | chr10:122595797..122596436-chr6:65107139..65107964,2 | MCF-7 | breast: | |
6 | chr6:65105555..65108214-chr6:65112608..65114216,2 | K562 | blood: | |
7 | chr6:65070131..65072480-chr6:65075607..65077474,2 | MCF-7 | breast: |
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PHF3-2 | chr6:65087688-65087825 | ENSG00000232120.1 |
2 | lnc-PHF3-2 | chr6:65089477-65089605 | ENSG00000232120.1 |
3 | lnc-PHF3-2 | chr6:65110209-65110322 | ENSG00000232120.1 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000232120 | TF binding region |
ENSG00000232120 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs575570859 | chr6:65066626-65066627 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs569639908 | chr6:65066629-65066630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs192001655 | chr6:65066653-65066654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs373342557 | chr6:65066655-65066656 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs557593900 | chr6:65066658-65066659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs73767535 | chr6:65066723-65066724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs544193620 | chr6:65066769-65066770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs184154089 | chr6:65066781-65066782 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs561458247 | chr6:65066808-65066809 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs146913173 | chr6:65066856-65066857 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs139219184 | chr6:65066895-65066896 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs112439602 | chr6:65066940-65066941 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs73767537 | chr6:65067002-65067003 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs537232922 | chr6:65067028-65067029 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs552919891 | chr6:65067113-65067114 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs376741992 | chr6:65067219-65067220 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs35891882 | chr6:65067220-65067221 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs55747236 | chr6:65067223-65067224 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs200193074 | chr6:65067224-65067225 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs201307908 | chr6:65067226-65067227 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs571110822 | chr6:65067278-65067279 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs528704250 | chr6:65067290-65067291 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs372315826 | chr6:65067313-65067314 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs574054282 | chr6:65067324-65067325 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs79448207 | chr6:65067328-65067329 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs637362 | chr6:65067351-65067352 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs535601569 | chr6:65067357-65067358 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs143178006 | chr6:65067381-65067382 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs10944484 | chr6:65067404-65067405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs150881344 | chr6:65067412-65067413 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs571468157 | chr6:65067457-65067458 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs10806431 | chr6:65067460-65067461 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs139282952 | chr6:65067485-65067486 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs112236264 | chr6:65067492-65067493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs539539071 | chr6:65067511-65067512 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs115101156 | chr6:65067527-65067528 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs188581777 | chr6:65067531-65067532 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs78780450 | chr6:65067568-65067569 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs626316 | chr6:65067582-65067583 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs114547207 | chr6:65067585-65067586 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs528840775 | chr6:65067617-65067618 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs73453243 | chr6:65067636-65067637 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs191486486 | chr6:65067643-65067644 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs529451872 | chr6:65067676-65067677 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs550814254 | chr6:65067765-65067766 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs575883604 | chr6:65067810-65067811 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs625112 | chr6:65067813-65067814 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs561326043 | chr6:65067832-65067833 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs551403938 | chr6:65067948-65067949 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs528940910 | chr6:65067956-65067957 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164920 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian cancer | 19835627 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Epilepsy | 20502679 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:65066600-65067000 | Enhancers | Adipose Nuclei | Adipose |
2 | chr6:65067000-65067400 | Weak transcription | Adipose Nuclei | Adipose |
3 | chr6:65067400-65068000 | Enhancers | Adipose Nuclei | Adipose |
4 | chr6:65084400-65084800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr6:65084600-65085400 | Enhancers | Placenta Amnion | Placenta Amnion |
6 | chr6:65085400-65086600 | Weak transcription | Placenta Amnion | Placenta Amnion |
7 | chr6:65085600-65087000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
8 | chr6:65086000-65087000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
9 | chr6:65086000-65087000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
10 | chr6:65086200-65086400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
11 | chr6:65086600-65087000 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
12 | chr6:65086800-65087000 | Enhancers | Placenta Amnion | Placenta Amnion |
13 | chr6:65091600-65091800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
14 | chr6:65091800-65092200 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
15 | chr6:65094600-65095400 | Enhancers | Fetal Heart | heart |
16 | chr6:65095600-65096000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
17 | chr6:65112400-65112600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |